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Abstract
Background:  The human gut harbors a diverse community of microorganisms which serve
numerous important functions for the host wellbeing. Functional foods are commonly used to
modulate the composition of the gut microbiota contributing to the maintenance of the host health
or prevention of disease. In the present study, we characterized the impact of one month intake of
a synbiotic food, containing fructooligosaccharides and the probiotic strains Lactobacillus helveticus
Bar13 and Bifidobacterium longum Bar33, on the gut microbiota composition and metabolic profiles
of 20 healthy subjects.
Results: The synbiotic food did not modify the overall structure of the gut microbiome, as
indicated by Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis (PCR-DGGE).
The ability of the probiotic L. helveticus and B. longum strains to pass through the gastrointestinal
tract was hypothesized on the basis of real-time PCR data. In spite of a stable microbiota, the intake
of the synbiotic food resulted in a shift of the fecal metabolic profiles, highlighted by the Gas
Chromatography Mass Spectrometry Solid Phase Micro-Extraction (GC-MS/SPME) analysis. The
extent of short chain fatty acids (SCFA), ketones, carbon disulfide and methyl acetate was
significantly affected by the synbiotic food consumption. Furthermore, the Canonical discriminant
Analysis of Principal coordinates (CAP) of GC-MS/SPME profiles allowed a separation of the stool
samples recovered before and after the consumption of the functional food.
Conclusion: In this study we investigated the global impact of a dietary intervention on the gut
ecology and metabolism in healthy humans. We demonstrated that the intake of a synbiotic food
leads to a modulation of the gut metabolic activities with a maintenance of the gut biostructure. In
particular, the significant increase of SCFA, ketones, carbon disulfide and methyl acetate following
the feeding period suggests potential health promoting effects of the synbiotic food.
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Background
Humans can be considered as "superorganisms" with an
internal ecosystem of diverse symbiotic microorganisms
and parasites that have interactive metabolic processes.
Their homeostatic balance is dependent upon the interac-
tions between the host and its microbial components [1].
The human intestine is home to some 100 trillion micro-
organisms of at least 1000 species. The density of bacterial
cells in the colon has been estimated at 1011 to 1012 per
ml, which makes it one of the most densely populated
microbial habitats known [2,3]. This microbial ecosystem
serves numerous important functions for the human host,
including protection against pathogens, nutrient process-
ing, stimulation of angiogenesis, modulation of intestinal
immune response and regulation of host fat storage [4,5].
The composition of the adult gastrointestinal microbiota
has been intensely studied, using both cultivation and,
more recently, culture-independent, small subunit (SSU)
ribosomal DNA (rDNA) sequence-based methods [6-8].
Members of the anaerobic genera Bacteroides, Eubacterium,
Clostridium, Ruminococcus, and Faecalibacterium have typi-
cally been found to comprise a large majority of the
human adult gut microbial community. In healthy adults,
the gut microbiota consists of a stable individual core of
colonizing microorganisms surrounded by temporal visi-
tors [9,10]. Fluctuations around this core of phylotypes
are due to host genotype, diet, age, sex, organic disease
and drugs (especially antibiotics) [11]. It has been shown
that the microbiota structure strongly influences the gut
metabolic phenotype [12,13]. On short time scales, the
host-specific effects are relatively constant and changes in
the gut microbiome composition and activities are closely
influenced by dietary variations.
An increasing awareness of the potential of gut microor-
ganisms to influence human health has led to widespread
investigation of the relationship between the gut microbi-
ota and nutrients, particularly probiotics [14] and prebi-
otics [15] and their impact on the digestive system.
Members of the genera Bifidobacterium and Lactobacillus,
natural components of the colonic microbiota, are the
most commonly used probiotic bacteria in many func-
tional foods and dietary supplements [16]. Postulated
health advantages associated to bifidobacteria and lacto-
bacilli include the inhibition of pathogenic microorgan-
isms, improvement of lactose digestion, reduction of
serum cholesterol levels, prevention of cancer and
enhancement of the host's immune system [17,18]. Sev-
eral oligosaccharides have been studied as potential preb-
iotics, including lactulose, galactooligosaccharides and
fructooligosaccharides (FOS) [19]. Dietary supplements
of prebiotics increase the content and proportion of bifi-
dobacteria [20] and exert positive effects on absorption of
nutrients and minerals, synthesis of vitamins, prevention
of constipation, colon cancer, and improvement of blood
sugar and lipid profile [21]. Another possibility in the
microbiota modulation is the use of synbiotics, in which
probiotics and prebiotics are used in combination. This
combination improves the survival of the probiotic
strains, because specific substrates are readily available for
their fermentation, and results in advantages to the host
that the live microorganisms and prebiotics offer [11].
The inadequacy of conventional culture techniques to
reflect the microbial diversity of the intestinal ecosystem
has triggered the development of culture-independent
16S rRNA gene-based techniques for the evaluation of the
effects of functional food administration in humans
[22,23]. The latest frontier in the characterization of
uncultured and complex microbial communities is the
high-throughput technology of pyrosequencing, which
achieves hundreds of thousands of sequences of a specific
variable region within the small subunit of rRNA gene,
consequently revealing the full diversity of an ecosystem
[24,25]. However, since this approach is extremely labor
intensive and time consuming, PCR-DGGE and real-time
PCR represent population fingerprinting methods, com-
monly used to analyze the intestinal microbiota upon die-
tary intervention. PCR-DGGE allows the visualization of
the predominant genetic diversity without prior knowl-
edge of the composition or complexity of the microbial
ecosystem present in the sample [23,26]. Real-time PCR
enables specific intestinal bacterial populations to be
directly quantified by using DNA isolated from fecal
material [23,27-29].
Gene expression profiling and proteomic approaches
have been applied to elucidate the molecular mechanisms
underlying symbiotic host-bacterial relationships [30-32].
However, gene expression and proteomic data might only
indicate the potential for physiological changes because
many pathway feedback mechanisms are simply not
reflected in protein concentration or gene expression. On
the other hand, metabolite concentrations and their
kinetic variations in tissues or biological matrixes repre-
sent real end-points of physiological regulatory processes
[1,33]. Metabonomics is defined as "the quantitative
measurement of the dynamic multiparametric metabolic
response of living systems to pathophysiological stimuli
or genetic modification" [34]. Metabonomics provides a
systems approach to understand global metabolic regula-
tion of an organism and its commensal and symbiotic
partners [1]. Recently, complementary metabonomic
approaches have been employed for the biochemical
characterization of metabolic changes triggered by gut
microbiota, dietary variation and stress interactions [35-
39]. Solid phase microextraction followed by gaschroma-
tography and mass spectrometry represents a novel
method for studying metabolic profiles of biological sam-
ples. This approach has been used to compare neonatesBMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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and adult feces [40] and to identify volatile markers of
gastrointestinal disease [41].
In the present study, we characterized the impact of the
intake of a synbiotic snack on the gut microbiota compo-
sition and metabolic profiles of healthy subjects. The syn-
biotic snack contained the substrate FOS, whose prebiotic
effects are widely documented [42], and the probiotic
strains  Lactobacillus helveticus Bar13 and Bifidobacterium
longum Bar33, which were selected on the basis of their
adhesion and immune-regolation properties, as assessed
by both in vitro [43] and in vivo studies on animal models
[44]. Co-variations were searched between the gut micro-
biome structure, as reflected by community DNA finger-
prints derived from PCR-DGGE and real-time PCR data,
and host metabolic phenotypes, as detected by GC-MS/
SPME.
Results
Effects of the synbiotic food on composition of the gut 
microbiota
PCR-DGGE analysis with universal primers targeting the
V2-V3 region of the 16S rRNA gene was used to monitor
the impact of the synbiotic food intake on the predomi-
nant bacterial population (Figure 1A). Population finger-
print profiles were compared and numerically analyzed
by FPQuest Software. DGGE band profiles (mean of
bands: 15.3) were stable for each subject over a month of
feeding with the functional food. Only a slight difference
in band richness was found between the time points of the
study (T0, mean of bands: 15.8; T1, mean of bands: 14.8).
DGGE bands were subjected to Mann-Whitney U-test in
order to search for significant differences in the intensities
between T0 and T1. No band showed a significant varia-
tion, indicating that the consumption of the synbiotic
food did not alter the concentration of any major species
of intestinal microbiota. Pearson correlation was used to
calculate the similarity index (SI) between DGGE band
profiles related to the time points T0 and T1 for each
healthy volunteer (Table 1). The high median value of SI
(67.1%) revealed that the dominant bacterial composi-
tion remained constant over the treatment. Only 3 sub-
jects presented SIs lower than 50% (subjects 8, 12 and
20). No subject showed significant variations between
DGGE band profiles related to T0 and T1, as evaluated
using the Pearson correlation analysis (P > 0.05).
Cluster analysis of DGGE population profiling confirmed
the stability of the overall structure of the microbiome,
revealing no grouping according to the feeding (Figure 1B-
C). T0 and T1 banding patterns were closely related for all
the volunteers, except for the subject 8 (SI: 47.7%).
Among different subjects, considerable variation in the
composition of the population fingerprints could be
observed. Both qualitative (presence or absence of a
band) or quantitative (variable intensity of a band) varia-
tions did occur. These inter-individual variations were
higher than changes elicited by the functional food con-
sumed.
Quantitative variations of bifidobacteria and lactobacilli
In order to evaluate the effect of the prebiotic component
on modulation of bifidobacteria and lactobacilli popula-
tions and the capability of the probiotic bacteria to pass
through the gut of the healthy host, quantitative varia-
tions of Bifidobacterium  and  Lactobacillus  genera were
determined by real-time PCR and compared to the varia-
tions of the species B. longum and L. helveticus (Table 2).
All volunteers naturally harbored strains belonging to Bifi-
dobacterium and Lactobacillus, as demonstrated by the pres-
ence of these genera in all stool samples recovered before
the beginning of the feeding trial. B. longum was also
found in all healthy subjects at the time point T0, in
accordance with previous studies reporting B. longum as
one of the major bifidobacterial species in the intestinal
microbiota of human adults [29]. Differently, L. helveticus
was detected only in 8 subjects at the time point T0, show-
ing a frequency of 40%. L. helveticus is not a normal inhab-
itant of the intestinal microbiota, but strains belonging to
this species are used as starter cultures in the manufactur-
ing of a variety of fermented dairy products, to modulate
flavor. Thus, presence of L. helveticus in fecal samples can
be related to a diet rich in yogurt and cheese [45]. Table 2
highlights different trends of variation of Bifidobacterium,
Table 1: Similarity index (SI) of DGGE profiles related to T0 and 
T1
Subject SI (%)
17 1 . 8
26 0 . 6
37 9 . 2
45 4 . 1
59 1 . 3
65 5 . 9
77 7 . 5
84 7 . 7
96 5 . 0
10 89.3
11 80.9
12 38.2
13 76.1
14 64.7
15 66.6
16 59.4
17 80.3
18 64.3
19 72.1
20 46.4BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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DGGE analysis of the fecal samples recovered from 20 healthy volunteers (s1-s20) before (T0) and after (T1) one month of the  synbiotic intake Figure 1
DGGE analysis of the fecal samples recovered from 20 healthy volunteers (s1-s20) before (T0) and after (T1) 
one month of the synbiotic intake. A: DGGE profiles related to fecal samples and L. helveticus Bar13 and B. longum Bar33 
probiotic strains. B: line graph. C: Cluster analysis (Pearson correlation was used to calculate the similarity in DGGE profiles).
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Lactobacillus, B. longum and L. helveticus concentrations
among the subjects enrolled in the trial, suggesting a spe-
cific individual response to the dietary intervention. This
variability is particularly evident for L. helveticus. In the
majority of the volunteers, the synbiotic intake was asso-
ciated to an increase or to the appearance of this species.
In 2 subjects (4 and 9) no variation was found at the time
point T1. In 4 subjects (6, 8, 19 and 20) L. helveticus did
not appear after the feeding period and in the subject 20
it disappeared at the time point T1. These results indicate
that the capability of L. helveticus Bar 13 to persist in the
gastrointestinal tract is related to the specific characteris-
tics of the host gut environment.
In order to assess the global impact of the functional food
consumption on the bifidobacteria and lactobacilli popu-
lations, a statistical elaboration of the real-time PCR data
was performed. Box plots in Figure 2 show the amounts of
16S  rrn  operons of Bifidobacterium  (A),  B. longum (B),
Lactobacillus (C) and L. helveticus (D) detected at the time
points T0 and T1 of the feeding study. The intake of the
synbiotic food did not cause significant variations in the
median value of Bifidobacterium (T0: 2.6 × 107; T1: 2.2 ×
107), B. longum (T0: 4.7 × 106; T1: 5.1 × 106) and Lactoba-
cillus (T0: 8.5 × 105; T1: 6.5 × 105). On the contrary, a sig-
nificant increase (P  < 0.05) of L. helveticus DNA was
observed after the administration of the functional food
Table 2: Real-time PCR quantification of bifidobacteria and lactobacilli
Subject Time point 16S rrn operons/μg fecal genomic DNA (mean ± SD)
Bifidobacterium B. longum Lactobacillus L. helveticus
1T 0 9 . 4  ×  1 0 6 ± 3.7 × 106 3.2 × 106 ± 1.5 × 106 2.6 × 106 ± 9.6 × 105 0.0 ± 0.0
T1 4.1 × 106 ± 8.3 × 105 1.1 × 106 ± 2.9 × 105 1.9 × 106 ± 9.9 × 105 4.5 × 102 ± 2.9 × 102
2T 0 8 . 9  ×  1 0 7 ± 3.1 × 107 4.2 × 107 ± 3.6 × 107 1.1 × 105 ± 5.6 × 104 9.0 × 101 ± 6.2 × 101
T1 1.6 × 107 ± 5.0 × 106 4.7 × 106 ± 2.9 × 105 5.1 × 105 ± 2.4 × 105 2.6 × 103 ± 2.8 × 102
3T 0 4 . 0  ×  1 0 8 ± 3.6 × 107 8.6 × 106 ± 2.6 × 106 5.6 × 104 ± 3.5 × 104 0.0 ± 0.0
T1 2.4 × 108 ± 2.5 × 107 2.4 × 107 ± 2.9 × 106 2.6 × 105 ± 1.6 × 105 2.8 × 103 ± 1.8 × 103
4T 0 2 . 6  ×  1 0 8 ± 2.8 × 107 2.3 × 107 ± 2.9 × 106 1.6 × 105 ± 1.0 × 103 2.1 × 103 ± 8.7 × 101
T1 5.8 × 108 ± 1.2 × 107 3.7 × 107 ± 3.1 × 106 1.2 × 105 ± 2.7 × 104 1.6 × 103 ± 2.2 × 102
5T 0 3 . 1  ×  1 0 6 ± 8.6 × 105 9.8 × 105 ± 2.8 × 105 1.9 × 104 ± 5.8 × 103 0.0 ± 0.0
T1 2.4 × 106 ± 7.3 × 105 9.5 × 105 ± 3.4 × 105 6.1 × 104 ± 3.4 × 104 3.5 × 102 ± 2.3 × 102
6T 0 1 . 7  ×  1 0 8 ± 3.8 × 107 6.5 × 106 ± 2.4 × 105 2.7 × 105 ± 1.2 × 105 0.0 ± 0.0
T1 6.2 × 108 ± 4.2 × 107 3.5 × 107 ± 2.0 × 105 1.7 × 105 ± 1.1 × 105 0.0 ± 0.0
7T 0 6 . 4  ×  1 0 7 ± 4.8 × 106 3.4 × 107 ± 1.2 × 106 4.0 × 105 ± 1.7 × 105 9.0 × 101 ± 8.2 × 101
T1 7.5 × 107 ± 1.2 × 106 4.6 × 107 ± 5.5 × 106 9.2 × 105 ± 4.9 × 105 1.4 × 104 ± 3.2 × 103
8T 0 1 . 8  ×  1 0 6 ± 5.8 × 105 6.0 × 105 ± 3.6 × 105 1.0 × 106 ± 1.0 × 106 0.0 ± 0.0
T1 4.1 × 106 ± 8.5 × 105 1.3 × 106 ± 9.7 × 105 1.7 × 105 ± 1.7 × 105 0.0 ± 0.0
9T 0 4 . 4  ×  1 0 6 ± 2.8 × 105 3.0 × 106 ± 2.3 × 106 9.2 × 105 ± 9.0 × 105 3.0 × 103 ± 1.1 × 103
T1 5.6 × 106 ± 1.4 × 105 3.8 × 106 ± 1.3 × 106 2.0 × 106 ± 1.0 × 106 1.8 × 103 ± 1.7 × 103
10 T0 1.0 × 108 ± 1.8 × 107 7.0 × 107 ± 4.5 × 107 7.7 × 105 ± 7.6 × 105 0.0 ± 0.0
T1 3.3 × 108 ± 7.7 × 107 4.3 × 107 ± 2.5 × 107 1.3 × 106 ± 1.2 × 106 3.2 × 103 ± 2.7 × 103
11 T0 4.1 × 106 ± 7.5 × 105 1.2 × 106 ± 2.5 × 105 5.1 × 105 ± 4.1 × 105 6.0 × 102 ± 3.8 × 102
T1 3.4 × 107 ± 6.2 × 105 3.1 × 107 ± 1.0 × 107 7.8 × 105 ± 7.7 × 105 1.7 × 104 ± 3.1 × 103
12 T0 3.4 × 105 ± 7.6 × 104 7.5 × 102 ± 3.0 × 101 1.7 × 107 ± 1.1 × 107 0.0 ± 0.0
T1 1.3 × 106 ± 7.0 × 105 2.0 × 105 ± 9.3 × 104 5.8 × 105 ± 5.6 × 105 3.6 × 103 ± 6.4 × 102
13 T0 3.5 × 107 ± 1.6 × 106 1.2 × 107 ± 2.6 × 105 1.8 × 105 ± 1.0 × 105 0.0 ± 0.0
T1 2.3 × 107 ± 3.8 × 106 4.6 × 106 ± 4.4 × 105 2.5 × 105 ± 1.8 × 105 1.8 × 102 ± 4.3 × 101
14 T0 1.1 × 107 ± 6.9 × 105 2.3 × 106 ± 1.6 × 106 1.1 × 106 ± 1.8 × 105 0.0 ± 0.0
T1 5.4 × 107 ± 1.7 × 107 1.0 × 107 ± 6.5 × 106 7.2 × 105 ± 6.4 × 105 3.0 × 102 ± 3.0 × 101
15 T0 6.1 × 107 ± 7.4 × 106 1.7 × 107 ± 8.3 × 106 3.9 × 105 ± 2.9 × 105 1.8 × 101 ± 1.6 × 101
T1 2.5 × 107 ± 5.3 × 106 1.0 × 107 ± 5.8 × 106 2.5 × 105 ± 2.2 × 105 3.2 × 102 ± 1.4 × 102
16 T0 1.3 × 109 ± 4.5 × 108 4.0 × 107 ± 1.2 × 107 2.0 × 106 ± 1.1 × 106 0.0 ± 0.0
T1 1.3 × 109 ± 2.0 × 108 2.2 × 107 ± 3.8 × 106 1.0 × 106 ± 8.2 × 105 8.3 × 102 ± 1.4 × 101
17 T0 1.6 × 107 ± 1.6 × 106 5.0 × 106 ± 3.2 × 106 1.3 × 107 ± 2.9 × 106 1.3 × 102 ± 1.1 × 102
T1 2.2 × 107 ± 1.9 × 106 4.0 × 106 ± 2.7 × 106 1.5 × 107 ± 2.0 × 105 6.6 × 102 ± 9.5 × 101
18 T0 1.1 × 105 ± 3.1 × 106 1.4 × 103 ± 4.4 × 102 3.1 × 107 ± 2.7 × 107 0.0 ± 0.0
T1 3.7 × 105 ± 8.9 × 104 1.7 × 105 ± 7.3 × 104 3.0 × 106 ± 1.2 × 106 6.5 × 102 ± 1.2 × 102
19 T0 5.2 × 107 ± 1.7 × 107 4.3 × 105 ± 1.8 × 105 2.5 × 106 ± 1.9 × 106 0.0 ± 0.0
T1 2.0 × 107 ± 8.0 × 106 1.5 × 105 ± 9.4 × 104 2.0 × 106 ± 1.5 × 106 0.0 ± 0.0
20 T0 6.6 × 106 ± 5.2 × 106 4.4 × 106 ± 2.2 × 106 1.0 × 107 ± 8.4 × 106 1.8 × 103 ± 2.6 × 102
T1 7.0 × 106 ± 3.3 × 105 5.5 × 106 ± 3.3 × 106 2.7 × 105 ± 2.6 × 105 0.0 ± 0.0BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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(T0 median value: 0; T1 median value: 6.6 × 102), demon-
strating the ability of L. helveticus Bar13 to pass through
the gut of healthy humans. The significant increase of L.
helveticus was directly linked to the low incidence of this
species in the intestine of the human host. Analogously,
the absence of significant variations in Bifidobacterium,
Lactobacillus and B. longum could be related to the high T0
amounts of these bacterial groups, natural inhabitants of
the gut microbiota of healthy humans. Amounts of L. hel-
veticus were evaluated by real-time PCR in stool samples
recovered from 10 subjects after a wash-out period of 20
days. Concentration of this species returned to a median
value of 0, supporting the hypothesis of a transient per-
sistence of the probiotic strain Bar13 during the feeding
period (data not shown).
Figure 3 shows the relationship between the variation of
B. longum species, expressed as the ratio of T1 and T0 16S
rrn operons, and the basal concentration of B. longum,
expressed as the number of 16S rrn operons measured at
the time point T0. The trend of the curve indicates a strong
influence of the initial concentration of B. longum on the
variation of B. longum population after the feeding period.
An evident increase of B. longum was observed in subjects
11, 12 and 18, who showed T0 amount of this species
minor or equal to 1.0 × 106 16S rrn operons per μg of total
bacterial DNA. Notably, subject 12, presenting the lowest
B. longum concentration at the time point T0 (7.5 × 102),
showed the highest variation of B. longum (T1/T0: 2.6 ×
Real-time PCR evaluation of 16S rrn operons of Bifidobacte- rium (A), B. longum (B), Lactobacillus (C) and L. helveticus (D)  related to the time points (T0 and T1) of the feeding study Figure 2
Real-time PCR evaluation of 16S rrn operons of Bifi-
dobacterium (A), B. longum (B), Lactobacillus (C) and 
L. helveticus (D) related to the time points (T0 and 
T1) of the feeding study. Data are expressed as number 
of operons in 1 μg of total bacterial DNA extracted from the 
feces. The box represents the interquartile range (25-75th 
percentile) and the line within the box is the median value. 
The bottom and top bars indicate the 10th and 90th percen-
tiles, respectively. Outlier values are indicated (black circles). 
* indicates a significant difference (P < 0.05).
Relationship between B. longum variations (T1/T0 16S rrn  operons) and B. longum amount before the feeding trial (T0  16S rrn operons) Figure 3
Relationship between B. longum variations (T1/T0 
16S rrn operons) and B. longum amount before the 
feeding trial (T0 16S rrn operons). Empty circles indicate 
subjects with T0 value minor or equal to 1.0 × 106 16S rrn 
operons per μg of total bacterial DNA. Filled circles indicate 
subjects with T0 value higher than 1.0 × 106 16S rrn operons 
per μg of total bacterial DNA.BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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102) after the synbiotic intake. The same subject presented
the lowest SI (38.2%) between DGGE band profiles
related to the time points T0 and T1. These data suggest
the capability of B. longum Bar33 to pass through the
human gastrointestinal tract, but this property can be
detected only in subjects harboring low basal level of B.
longum species.
Changes in intestinal metabolic profiles
In this investigation about 130 different metabolites
belonging to the families of alcohols, ketones, aldehydes,
sulfur compounds, nitrogen compounds and SCFA were
detected in feces by means of GC-MS/SPME analysis (see
Additional file 1). A two-tailed Mann-Whitney test was
performed on the metabolic data matrix in order to iden-
tify the molecules significantly affected by the consump-
tion of the functional food. A CAP analysis performed on
the selected molecules evidenced that metabolites whose
changes were positively correlated with the synbiotic
administration principally belonged to the families of
ketones (methyl-5-hepten-2-one, 2-propanone, 2-
butanone, 2-pentanone, 2,3-butanedione) and SCFA
(acetic and valeric acid). Differently, the concentration of
1-octanol, thiophene and nonanone decreased signifi-
cantly after the feeding period. These results are showed in
the Figure 4, which reports the loadings plot obtained
from the CAP analysis. The scores plot (canonical axe)
obtained from the same supervised method showed a per-
fect classification of the samples, on the basis of the syn-
biotic food intake (Figure 5). The application of the CAP
analysis on metabolites data set characterized by GC-MS/
SPME resulted in classification and predictive abilities of
100% (see Additional file 2), as evaluated by the leave-
four-out procedure used, using only a reduced number of
experimental chromatographic peaks as input variables.
CAP loadings plot of metabolites whose concentration was significantly affected by the intake of the synbiotic food (P < 0.05) Figure 4
CAP loadings plot of metabolites whose concentration was significantly affected by the intake of the synbiotic 
food (P < 0.05). Positive and negative coefficients indicate the increase or decrease of metabolite amounts following the feed-
ing period.BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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Discussion
The significant involvement of the gut microbiota in the
human health suggests that modulation of commensal
microbial composition and metabolism through combi-
nations of probiotics and prebiotics could be a dietary
strategy to prevent diverse diseases, such as obesity, diabe-
tes, non-alcoholic fatty liver disease, inflammatory bowel
disease, and even cancers [4].
In the present study, the impact of a synbiotic food sup-
plement on the gut microbiota structure of healthy
humans was evaluated by using an integrated molecular
approach based on PCR-DGGE and real-time PCR.
DGGE profiles of the predominant fecal microbiota gen-
erated complex but overall relatively stable and unique
profiles for each individual. Elaboration of DGGE data
revealed high SI values between T0 and T1 profiles, and
no clustering of banding patterns according to the feed-
ing. These results demonstrated that no significant change
in the structure of the gut microbiota of healthy subjects
did occur following dietary intervention, confirming pre-
vious findings regarding the subject specificity of the pre-
dominant fecal communities and their stability over time
and resistance to perturbations [9,23]. Notably, we cannot
exclude an effect of the synbiotic intake on minor bacte-
rial species, an effect that could be investigated using high-
CAP scores plot of the stool samples collected from the twenty volunteers before (T0) and after (T1) the synbiotic food intake Figure 5
CAP scores plot of the stool samples collected from the twenty volunteers before (T0) and after (T1) the syn-
biotic food intake.
T0 T1BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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throughput sequencing techniques. However, the impact
on the dominant colonic microbiota represents the main
parameter to evaluate the clinical relevance for the use of
a functional food.
Because DGGE can be considered a semiquantitative tool
for monitoring the dynamics of the predominant bacterial
species of an ecosystem, additional analysis with real-time
PCR was performed to obtain a quantitative estimation of
the effect of the synbiotic intake on bifidobacteria and
lactobacilli populations. In particular, variations in
amounts of B. longum and L. helveticus were evaluated in
order to assess the capability of the probiotic species
included in the synbiotic food to pass through the gas-
trointestinal tract of the human host. Only L. helveticus
concentration increased significantly after the ingestion of
the functional food, demonstrating the gut persistence of
the probiotic L. helveticus strain during the feeding period.
Since L. helveticus species is not a natural inhabitant of the
human intestine and its presence in feces is diet related
[45], this result was not surprising and suggests that low
abundant species could be optimal models for studying
the gut colonization of probiotic bacteria. On the other
hand, visualization of the gut colonization of a high
abundant species, such as B. longum, is strictly related to
its basal concentration. For this reason, we observed the B.
longum increase only in subjects with the lowest concen-
tration of B. longum species at the time point T0.
The intake of the synbiotic food resulted in significant
changes in some gut metabolic activities, as highlighted
by the CAP analysis of the fecal metabolic profiles, which
pointed out a separation of fecal samples of the subjects
on the basis of the synbiotic food intake. Surprisingly little
is known about volatile organic compounds formed in
the gut. GC-MS/SPME, detecting volatile molecules with
high sensitivity, represents a suitable approach to identify
microbial metabolites in fecal samples, such as SCFAs,
ketones, esters and sulfur compounds [46].
Two SCFAs, acetic and valeric acids, were the metabolites
showing the highest increase after the synbiotic adminis-
tration. Although a general increase was observed also for
butyric acid, this variation was not statistically significant
due to the high variability of the measures. SCFAs are very
common in the gut environment, arising from metabo-
lism of undigested carbohydrates, such as dietary fiber
and prebiotics, by colonic bacteria. The increase of SCFAs
is particularly interesting, as they play a role in regulation
of cell proliferation and differentiation of the colonic epi-
thelial cells. Increases in SCFA production have been asso-
ciated with decreased pH, which may reduce potential
pathogenic clostridia, decreased solubility of bile acids,
increased absorption of minerals, and reduced ammonia
absorption by the protonic dissociation of ammonia and
other amines [47]. Other metabolites whose changes were
positively and significantly correlated with the synbiotic
intake belonged to the family of methylketones (methyl-
5-hepten-2-one, 2-propanone, 2-butanone, 2-pentanone,
2,3-butanedione). In particular, the significant increase of
2-pentanone can be regarded as the most interesting effect
associated with the synbiotic food intake. In fact, 2-pen-
tanone, which is a naturally occurring compound in
fruits, vegetables and fermented foods, has anti-inflam-
matory and chemopreventive properties. According to
Pettersson et al. [48], it inhibits the prostaglandin produc-
tion and COX-2 protein expression in human colon can-
cer cells. The increase of 2,3-butanedione is interesting
since it may have health benefits by impacting on the
growth of some bacteria, such as L. delbrueckii subsp. bul-
garicus  ad  Streptococcus thermophilus [41]. Furthermore,
during glucose catabolism 2,3-butanedione serves as an
electron acceptor and can be reduced to 2,3-butanediol
via acetoin. This pathway was shown to be important in
the removal of toxic amounts of pyruvate and in mainte-
nance of pH homeostasis [49]. A diverse range of sulfur
compounds has been identified in stool samples [41]. The
usual source of sulfur compounds is the microbial break-
down of sulfur containing amino acids and the increase of
these compounds suggests an abundance or metabolic
activity of bacteria able to breakdown cystein and methio-
nine. In our study, a significant increase of carbon
disulfide was observed following the feeding period. Car-
bon disulfide may be produced by carbonation of hydro-
gen sulphide as a detoxification mechanism exerted by
colonic bacteria. According to Garner et al. [41], carbon
disulfide has been found in 100% of the samples from
healthy donors and absent in many samples of patients
with Campylobacter jejuni and Clostridium difficile. Various
esters were detected in all fecal samples. In particular, a
significant increase of methyl acetate, ester of methanol
and acetic acid, was evident after the synbiotic intake.
Methanol is rarely found as free alcohol in the gut, where
it is generated from the breakdown of macromolecules
including pectins, bran and aspartame. In general, free
alcohols and endogenous fatty acids are metabolized into
fatty acid esters in liver, pancreas and intestine [50]. At the
intestinal site, esterification of alcohols by colonic bacte-
ria can be regarded as a microbial strategy to remove or
trap toxic molecules such as fatty acids and alcohols.
To sum up, the investigation of the fecal volatile metabo-
lites by GC-MS/SPME allowed to correlate the consump-
tion of the synbiotic food with the stimulation of health-
promoting metabolic activities of the gut microbiota, such
as regulation of the colonic epithelial cell proliferation
and differentiation, anti-inflammatory and chemopreven-
tive properties and detoxification processes.BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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Conclusion
In the current study molecular fingerprinting techniques
(PCR-DGGE and real-time PCR) were integrated to the
GC-MS/SPME analysis of the metabolic profiles to inves-
tigate the global impact of a dietary intervention on the
gut ecology and metabolism in healthy humans. In partic-
ular, the major findings of this study are the following: (i)
the synbiotic food does not modify the overall structure of
the gut microbiome, as detected by DGGE; (ii) the gut sur-
vival of the probiotic strains may be supposed on the basis
of the increase of B. longum and L. helveticus after the syn-
biotic consumption; (iii) the perturbation of the gut
metabolism triggered by a synbiotic food intake generates
significant changes in the GC-MS/SPME profiles; (iv)
changes in metabolic phenotypes seem to indicate poten-
tial implications of the synbiotic food in health mainte-
nance and prevention of diverse diseases.
In order to better investigate the mechanistic basis of the
probiotics and prebiotics action on gut microbial activi-
ties and the outcomes on human health, it will be neces-
sary to integrate the GC-MS/SPME and/or NMR profiles of
feces with simultaneous analysis of different biofluids,
including urine and plasma.
Methods
Study population
Twenty randomly selected healthy volunteers (11 women
and 9 men) aged between 20 and 50 (mean: 35) partici-
pated in the study. The Ethics Committee of the University
of Bologna (Italy) approved the study, and all subjects
gave informed consent. None of the subjects had a history
of gastrointestinal or metabolic disease or previous sur-
gery (apart from appendectomy). The subjects did not
receive antibiotic treatment or any other medical treat-
ment influencing intestinal microbiota during 3 months
before the start of the study. Subjects maintained their
usual diet during the study period. All the volunteers had
normal weight with a body mass index in the range 18.5-
24.9. The volunteers received one dose of a synbiotic
snack (Barilla, Parma, Italy), twice a day for a period of 1
month. The synbiotic bar consisted of a biscuit covered by
chocolate. The biscuit contained 500 mg of FOS (Acti-
light® 950P, Marckolsheim, France) and the chocolate
included a mixture of the probiotic strains B. longum
Bar33 and L. helveticus Bar13 (Barilla culture collection).
109CFU of each probiotic strain were present in a dose of
the synbiotic bar.
Extraction of DNA from fecal samples
Stool samples were collected from volunteers before the
start of the feeding study (T0) and at the end of the inges-
tion period (T1) and immediately frozen at -80°C until
use. Total DNA was extracted from 230 mg of feces by
using QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Ger-
many), according to the manufacturer's instructions.
PCR-DGGE and cluster analysis
Amplification of the V2-V3 region of the bacterial 16S
rRNA gene was carried out using the universal eubacterial
primers GCclamp-HDA1 and HDA2 [51], supplied by M-
Medical (Milan, Italy). The amplification reactions were
performed in a Biometra Thermal Cycler T Gradient
(Biometra, Göttingen, Germany). AmpliTaq Gold DNA
Polymerase (Applied Biosystem, Foster City, CA) was used
as thermostable DNA polymerase. The reaction mixture
contained 0.5 μM of each primer, 200 μM of each dNTP,
0.5 U of DNA Polymerase, and 4 μl of the bacterial DNA
template in a final volume of 50 μl. The thermocycle pro-
gram consisted of the following time and temperature
profile: 95°C for 15 min; 30 cycles of 95°C for 60 s, 56°C
for 30 s, 72°C for 30 s; and 72°C for 8 min. A volume of
15-20 μl of PCR samples was used for DGGE analysis,
which was performed by using the D-Code Universal
Mutation System Apparatus (Bio-Rad, Los Angeles, CA),
as previously described [52]. Briefly, the sequence-specific
separation of the PCR fragments was obtained in 8% (w/
v) polyacrylamide gels, containing a 30% to 50% gradient
of urea and formamide. Electrophoresis was started at a
voltage of 250 V for 5 minutes and continued at constant
voltage of 90 V and temperature of 60°C for 16 h. Follow-
ing electrophoresis, the gel was silver stained [53] and
scanned using a Molecular Imager Gel Doc XR System
(Bio-Rad). DGGE gel images were analyzed using the
FPQuest Software Version 4.5 (Bio-Rad). In order to com-
pensate for gel-to-gel differences and external distortion
to electrophoresis, the DGGE patterns were aligned and
normalized using an external reference ladder, containing
PCR amplicons from pure cultures of intestinal bacterial
species. A cluster analysis of the DGGE patterns was per-
formed using the FPQuest Software. The similarity in the
profiles was calculated on the basis of the Pearson corre-
lation coefficient with the Ward clustering algorithm.
Development of L. helveticus species-specific primers
By using 16S and 16S-23S rRNA sequences obtained from
the DDBJ and EMBL databases, multiple alignments of
sequences related to L. helveticus and reference organisms
were constructed with the program Clustal W http://
www.ebi.ac.uk/Tools/clustalw2. Potential target sites for
specific detection of the species L. helveticus were identi-
fied and the following primers were designed: F_Hel (5'-
GTGCCATCCTAAGAGATTAGGA-3') and R_Hel (5'-
TATCTCTACTCTCCATCACTTC-3'). A Blast search http://
www.ncbi.nlm.nih.gov/BLAST was carried out to test the
virtual specificity of the primers. Validation of specificity
was performed by PCR experiments against different spe-
cies of Lactobacillus (L. acidophilus, L. casei, L. plantarum, L.BMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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bulgaricus, L. reuteri, L. gasseri, L. johnsonii) and other intes-
tinal genera (Bifidobacterium,  Streptococcus,  Escherichia).
The primers were synthesized by M-Medical (Milan, Italy)
and optimal annealing temperature was established by
gradient PCR.
Real-time quantitative PCR
Quantitative PCR was performed in a LightCycler instru-
ment (Roche, Mannheim, Germany) and SYBR Green I
fluorophore was used to correlate the amount of PCR
product with the fluorescence signal. The following
genus- and species-specific primers sets, targeted to 16S or
16S-23S rRNA sequences, were used: Bif164/Bif662 (Bifi-
dobacterium [54]); Lac1/Lab0677r (Lactobacillus [55,56]);
BiLON1/BiLON2 (B. longum [29]); F_Hel/R_Hel (L. helve-
ticus [this work]). Three sub-samples of each DNA extract
were amplified in a final volume of 20 μl containing 4
mM of MgCl2, 0.5 μM of each primer, 2 μl of LightCycler-
FastStart DNA Master SYBR Green I (Roche), and either 2
μl of template or water (no-template control). The ther-
mal cycling conditions were as follows: an initial denatur-
ation step at 95°C for 10 min followed by 40 cycles of
denaturation at 95°C for 15 s; primer annealing at 60°C
(Bifidobacterium), 65°C (Lactobacillus and B. longum) and
63°C (L. helveticus) for 25 s; extension at 72°C for 25 s
(Bifidobacterium), 20 s (Lactobacillus), 45 s (B. longum) and
10 s (L. helveticus) and a fluorescence acquisition step at
90°C (Bifidobacterium and B. longum) or 85°C (Lactobacil-
lus and L. helveticus) for 5 s. For each step the temperature
transition rate was 20°C/s. Quantification of rrn operons
of Bifidobacterium, Lactobacillus and B. longum was done by
using standard curves made from known concentrations
of genomic DNA from the sequenced strains B. longum
NCC2705 [30] and L. acidophilus NCFM [57]. For L. helve-
ticus species the probiotic strain included in the synbiotic
was used as standard and the number of rrn operons in
the genome was deduced from the sequenced genome of
L. helveticus DPC 4571 [58]. Chromosomal DNA of the
strains used as standards was extracted by using DNeasy
Tissue Kit (Qiagen) and serially diluted from 105 to 101
molecules/μl. Results obtained by PCR were converted to
the average estimate of total rrn operons from each group
present in 1 μg of total DNA, and standard deviations
(SD) were calculated.
GC-MS/SPME
A carboxen-polydimethylsiloxane coated fiber (85 μm)
and a manual SPME holder (Supelco, Bellefonte, PA) were
used in this study after preconditioning according to the
manufacturer's instruction manual. Before each head
space sampling, the fiber was exposed to the GC inlet for
5 min for thermal desorption at 250°C in a blank sample.
Five ml of fecal slurries (20%) were placed in 10 ml glass
vials, added with 4-methyl-2-pentanol (4 mg/l) as inter-
nal standard. The samples were then equilibrated for 10
min at 45°C. The SPME fiber was exposed to each sample
for 40 min and then was inserted into the injection port
of the GC for a 5 min sample desorption. GC-MS analyses
were performed on an Agilent 7890A gaschromatograph
(Agilent Technologies, Palo Alto, CA) coupled to an Agi-
lent 5975C mass selective detector operating in electron
impact mode (ionization voltage 70 eV). A Supelcowax 10
capillary column (60 m length, 0.32 mm ID) was used
(Supelco). The temperature program was: 50°C for 1 min,
then programmed at 4.5°C/min to 65°C and finally at
10°C/min to 230°C which was maintained for 25 min.
Injector, interface and ion source temperatures were 250,
250 and 230°C, respectively. The mass-to-charge ratio
interval was 30-350 Da at 2.9 scans per second. Injections
were performed in splitless mode and helium (1 ml/min)
was used as carrier gas. The identification of all the mole-
cules detected in fecal samples was based on comparison
of their retention times and spectral data with those of
pure compounds (Sigma-Aldrich, Milan, Italy) analyzed
in the same conditions. The identification was further
confirmed by comparing mass spectra of all compounds
with those contained in available databases (NIST version
2005 and Wiley version 1996) and in literature [41].
Quantitative data of the identified compounds were
obtained by interpolation of the relative areas versus the
internal standard area, in calibration curves built with
pure reference compounds. The concentration of volatile
compounds, for which there were no pure references, was
obtained by using the same calibration graphs of the com-
pounds with the most similar chemical structure.
Statistical analyses
For each subject, variations of the DGGE profiles related
to the time points T0 and T1 were analyzed by Pearson
correlation. Significant differences in the intensity of each
DGGE band among all fecal samples were searched by
using Mann-Whitney U-test. Mann-Whitney U-test was
also used to analyze differences in total rrn operons of tar-
get genera and species and to determine metabolites sig-
nificantly affected by the synbiotic food intake. A P value
below 0.05 was considered statistically significant. Metab-
olites with a P value below 0.05 were then used in further
multivariate analysis. These selected metabolites formed a
matrix containing two kinds of information: the effects of
the synbiotic food intake (within-individual variability)
and the natural differences between individuals (between-
individuals variability). These two kinds of information
were separated following the method of Jansen et al. [59].
A CAP analysis was then performed on the within-individ-
ual variability matrix [60]. The CAP constrained ordina-
tion procedure can be summarized as follows: the data
were reduced by performing a principal coordinate analy-
sis (PCO) on the parameters using a dissimilarity measure
based on Euclidean distances; an appropriate number of
PCOs were chosen non-arbitrarily, which maximize theBMC Microbiology 2010, 10:4 http://www.biomedcentral.com/1471-2180/10/4
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number of observations correctly classified [61,60]. The
robustness of the model obtained was established by a 4-
fold cross validation method, repeatedly leaving out a
fourth of the samples and predicting them back into the
model [62]. Finally a traditional canonical analysis on the
first three PCOs was performed. The hypothesis of no sig-
nificant difference in multivariate location among the
groups was tested by using a permutation test based on
9999 permutations.
Statistical analyses were performed using the software Sig-
maStat (Systat Sofware Inc., San Jose, CA) and the package
Canoco for Windows 4.5 (Microcomputer Power, Ithaca,
NY).
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